Navigation Links
Shengtai Pharmaceutical Retains Grayling Global As Investor Relations Counsel
Date:8/4/2008

WEIFANG, Shandong, China, Aug. 4 /Xinhua-PRNewswire-FirstCall/ -- Shengtai Pharmaceutical, Inc. (OTC Bulletin Board: SGTI) ("Shengtai Pharmaceutical" or "the Company"), a leading manufacturer and distributor of high-quality, pharmaceutical grade glucose products in China, today announced that it has retained Grayling Global to lead a strategic communications program ("the IR program") to shareholders, the investment community and financial media.

As the investor relations counsel for Shengtai Pharmaceutical, Grayling Global will help raise the investment community's awareness of the Company's performance through timely corporate updates, direct communications with fund managers, financial media placements and investor conference presentations. "We are pleased to have a global IR network and its senior counselors with long standing healthcare and industrial track records to help us raise our financial profile and ensure the full understanding of our business model and exciting growth prospects," said Mr. Qingtai Liu, Chief Executive Officer of Shengtai Pharmaceutical. "We need to increase our visibility and expand our relationships with U.S. investors. As we are becoming a bigger company and planning to move onto main exchange, we believe Grayling Global is best suited to guide this investor relations process."

Grayling Global, a subsidiary of Huntsworth PLC (LSE: HNT), is headquartered in London, with offices in New York, Brussels, Bangkok, Singapore, Madrid, Moscow, Tel Aviv, Hong Kong, Istanbul, Los Angeles, Sacramento, Dublin, Edinburgh, Cardiff, Bristol, and Birmingham. The firm has over 200 consultants, focusing on first-class delivery in public affairs, public relations, investor relations and events management.

About Shengtai Pharmaceutical, Inc.

Shengtai Pharmaceutical, Inc. through its wholly-owned subsidiary Shengtai Holding, Inc. (SHI), a New Jersey corporation, and the Chinese operating company of Weifang Shengtai Pharm
'/>"/>

SOURCE Shengtai Pharmaceutical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Shengtai Pharmaceutical, Inc. Appoints New CFO
2. Shengtai Pharmaceutical, Inc. Announces Conference Call to Discuss Second Quarter Results of Fiscal Year 2008
3. Huifeng Bio-Pharmaceutical (HFGB) to Release Second Quarter 2008 Earnings Results on August 15, 2008
4. Anacor Pharmaceuticals Appoints Dr. Kurt Jarnagin Vice President of Biological Research
5. Anadys Pharmaceuticals to Present at the Bank of America 2008 Specialty Pharmaceuticals Conference
6. VIA Pharmaceuticals to Present at 13th Annual IBC Life Sciences Drug Discovery & Development of Innovative Therapeutics World Congress
7. Onyx Pharmaceuticals to Present at Bank of America 2008 Specialty Pharmaceuticals Conference
8. Poniard Pharmaceuticals to Present at the 4th Annual Moores UCSD Cancer Center Translational Oncology Symposium
9. Idenix Pharmaceuticals to Present at the Bank of America 2008 Specialty Pharmaceuticals Conference
10. Vista Partners Updates Coverage on Raptor Pharmaceuticals Corp. (OTC Bulletin Board: RPTP)
11. Vanda Pharmaceuticals to Announce Second Quarter 2008 Financial Results on August 5, 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...ON, Nov. 9 The Appignan...nist Association, held a panel discussion today at...emerging technologies in biomedical sciences and c...Moreno and Andrew Light, both of the Center for Am...hical and political angles. ,, A video of the ...
(Date:11/9/2009)...EDLBERG, Austria, November 9 For m...ave been working on the development of a,Brain-Com...ion channel,between the brain and a computer. Such... communicate or to control devices in their enviro...rs some patients have been supervised by,the resea...
(Date:11/9/2009)... Four of the top 10 pharmaceutical gian...issions to Health Canada. Datafarm’s announc...Canadian DIA Annual Meeting where Health Canada st...s may submit Hybrid eCTD regulatory submissions fo...rior permission request. , ...
(Date:11/8/2009)...AIN VIEW, Calif. Nov. 5, 2009 Complete Genomics,...y, today announced publication of a report in the ...equencing platform, including analysis of sequence...mables cost for these three genomes sequenced on t...d from $8,005 for 87x coverage to $1,726 for 45x c...
Breaking Biology Technology:Jonathan Moreno and Andrew Light Speak About Biotechnology and Global Warming at the National Press Club 2Jonathan Moreno and Andrew Light Speak About Biotechnology and Global Warming at the National Press Club 3intendiX - Communication by Thoughts: First Patient-Ready System on the Market 2Datafarm Responds to Health Canada's Announcement of Hybrid eCTD Submission Procedural Simplification 2Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2
...therapy reversed hemophilia in mice , , GAITHERSB... today the publication of a new research article, ...nscripts for Production of Therapeutic Proteins I... study describes a novel RNA therapy technique in ...lbumin gene "hijacks" the albumin, causing it to p...
...LE, Ariz., April 6 MedTrust Online, announced tod...l Research Institute (SCRI) at Scottsdale Healthca...e knowledge discovery and collaboration tools at ...ill enable more access to the latest therapies to ...nt for physicians to find and communicate with eac...
... ACI EUROPE, CANSO, EUROCONTROL an...duce the CO2 emitted by aircraft in Europe by over... Geneva, Switzerland (PRWEB) April 6, 2009 ...d a joint action plan designed to reduce the CO2 e...n tonnes a year., , , , ,The plan, launched at the...
Other Biology Technology:VIRxSYS Publishes New Study on RNA Therapy 2MedTrust Online and Scottsdale Clinical Research Institute at Scottsdale Healthcare Announce Collaboration to Provide Cutting Edge Technology to Improve Patient Care 2Aviation partners to cut 500,000 tonnes of CO2 a year 2
(Date:11/9/2009)...gists have had their hands tied because more than ...ble a protein called p53. As a critical anti-cance...g operations within cells. When cells lose p53, tu.... , These tumors might be tough, but they,re no...g Harbor Laboratory (CSHL). The chink in the tumor...
(Date:11/9/2009)...ngs has inspired a 3.2m, three-year research proje...ds of security, energy and the environment. The Un...mpany QinetiQ have just signed a collaborative con...reaking physical sciences research. , Over the ...versity of Exeter and QinetiQ will work together t...
(Date:11/9/2009)... A nutritionist whose research was instrumental in..., Infants and Children (WIC) food subsidy will rec...tstanding achievement in the field of maternal-fet... professor in the Department of Community Health S...es School of Public Health, will receive the award...
Breaking Biology News(10 mins):CSHL study shows that some malignant tumors can be shut down after all 2CSHL study shows that some malignant tumors can be shut down after all 3£3.2m ($5.4 million) research project to capture brilliance of butterfly wings 2March of Dimes honors Dr. Gail Harrison for outstanding work in maternal-fetal nutrition 2New STR Systems from Promega Comply with Latest DNA Database Standards 14313 1New STR Systems from Promega Comply with Latest DNA Database Standards 14313 2Older Women May Sleep Better Than Men 58638 1Older Women May Sleep Better Than Men 58638 2Heart Pacing Devices Hold Promise for Heart Failure 58636 1Heart Pacing Devices Hold Promise for Heart Failure 58636 2
...N, N.J. Katherine Freed, undergraduate at Stevens...nternational ISPE Undergraduate Poster Contest in ...mpetitor from New Jersey to win this ISPE award. H...d on a project she created with her Senior Design ...gional ISPE Poster Contest was hosted by the Steve...
... release is available in Spanish . , Idiopathic ... with a very severe prognosis; when detected, it i... from it cannot develop with normality pulmonary g...fe. Because of lack of an effective treatment, the...iopathic pulmonary fibrosis affects 13 out of 100,...
...svirus May Play Role in Central Nervous System Dis...esting a herpesvirus may be responsible for some c...from the New York State Department of Public Healt...n the December 2007 issue of the Journal of Clinic... one of the most prevalent in humans. There are t...
Other Biology News:Katherine Freed wins first place at the International ISPE Undergraduate Poster Contest 2Translational research patented first experimental treatment against idiopathic pulmonary fibrosis 2Tips from the Journals of the American Society for Microbiology 2Tips from the Journals of the American Society for Microbiology 3
QIAshredder (50) from QIAGEN
...I 1640 medium with 2 mM L-glutamine and harvested ...antigens in their native forms, cells were fixed i...-well (5 mm) adhesive coated slide, with each well... attachment and to minimize background staining. ...
...PMI 1640 with 2 mM L-glutamine and harvested at th...ens in their native forms, cells were fixed in ace... (5 mm) adhesive coated slide, with each wells sur...chment and to minimize background staining. Each ...
Mouse Anti-Human XPMC2H Polyclonal Antibody, Unconjugated from Novus Biologicals
Biology Products: